Tris Pharma, Inc. v. Actavis Laboratories FL, Inc., et al., C.A. No. 14-1309 – GMS, January 8, 2016.
Sleet, J. Claim construction opinion issues regarding one term from four patents.
The disputed technology relates to pharmaceuticals. The following term was considered:
-
“single mean average plasma concentration peak”